ZHANG Jia-tao, YANG Xue-ning, WU Yi-long. Minimal Residual Disease: Leading The Cross-Age Biomarker for Lung Cancer[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 1-5. DOI: 10.12019/j.issn.1671-5144.2021.01.001
|
Citation:
|
ZHANG Jia-tao, YANG Xue-ning, WU Yi-long. Minimal Residual Disease: Leading The Cross-Age Biomarker for Lung Cancer[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 1-5. DOI: 10.12019/j.issn.1671-5144.2021.01.001
|
ZHANG Jia-tao, YANG Xue-ning, WU Yi-long. Minimal Residual Disease: Leading The Cross-Age Biomarker for Lung Cancer[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 1-5. DOI: 10.12019/j.issn.1671-5144.2021.01.001
|
Citation:
|
ZHANG Jia-tao, YANG Xue-ning, WU Yi-long. Minimal Residual Disease: Leading The Cross-Age Biomarker for Lung Cancer[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 1-5. DOI: 10.12019/j.issn.1671-5144.2021.01.001
|
DownLoad: